Aerie Pharmaceuticals, Inc.
(NASDAQ : AERI)

( )
AERI After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corporation Plc Sponsored ADR
0.54%18.491.8%$136.66m
ICPTIntercept Pharmaceuticals, Inc.
0.77%91.2318.6%$96.63m
SAGESAGE Therapeutics, Inc.
-1.51%164.468.8%$79.59m
JAZZJazz Pharmaceuticals Plc
-0.28%129.422.3%$71.74m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-2.74%161.036.3%$58.17m
PRGOPerrigo Co. Plc
-0.75%49.196.8%$54.20m
ZGNXZogenix, Inc.
1.79%38.069.9%$47.79m
UTHRUnited Therapeutics Corporation
-0.78%103.5014.3%$44.63m
CTLTCatalent Inc
-0.02%44.442.4%$40.01m
HZNPHorizon Pharma plc
-0.48%25.146.7%$34.23m
PTLAPortola Pharmaceuticals, Inc.
1.02%35.767.6%$33.53m
ICLRICON Plc
-0.28%134.674.1%$31.06m
ZYNEZynerba Pharmaceuticals Inc
1.11%10.018.3%$29.64m
MYOKMyoKardia, Inc.
-2.81%47.692.1%$25.34m
MNKMallinckrodt Plc
-0.87%18.2021.0%$24.91m

Company Profile

Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on June 22, 2005 and is headquartered in Durham, NC.